Filing Details

Accession Number:
0001213900-18-009128
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-12 17:11:48
Reporting Period:
2018-07-10
Accepted Time:
2018-07-12 17:11:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP Pharmaceutical Preparations (2834) 980376008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1351779 Nadav Kidron 142 W. 57Th St.
New York NY 10019
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-10 61 $5.98 958,087 No 4 S Direct
Common Stock Acquisiton 2018-07-11 122 $5.92 958,209 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 P Direct
Footnotes
  1. On July 12, 2018, Mr. Kidron paid to Oramed Pharmaceuticals Inc. $3.88, representing the full amount of the profit realized in connection with these short-swing transactions.